Evidence map›Paper›PMID 37044064›Full record

ArticleImmunity2023

Pathogen metabolite checkpoint: NHR on guard.

Rejane Rua, Nathalie Pujol

Open access · greenAbstract readComment
PubMed Publisher
In one paragraph

Article in Immunity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Modeling Host-Pathogen Interactions inInternational journal of molecular sciences · 2024
    Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rejane RuaAix-Marseille University, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy (CIML), Turing Centre for Living Systems, Marseille, France. Electronic address: rua@iml.univ-mrs.fr.
Nathalie PujolAix-Marseille University, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy (CIML), Turing Centre for Living Systems, Marseille, France. Electronic address: pujol@ciml.univ-mrs.fr.
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

How can beneficial microorganisms be distinguished from pathogenic ones? In this issue of Immunity, Peterson et al. discovered that a specific phenazine, which is part of a family of toxic metabolites expressed by pathogenic bacteria, is detected by Caenorhabditis elegans by directly binding to a nuclear hormone receptor, promoting the expression of detoxifying enzymes and immunity-related genes, thus protecting the worm.

Indexed as

Caenorhabditis elegans ProteinsAnimalsCaenorhabditis elegansGene Expression RegulationReceptors, Cytoplasmic and NuclearSignal TransductionCaenorhabditis elegans ProteinsReceptors, Cytoplasmic and Nuclear

Identifiers

PMID37044064
OpenAlexW4364360891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.